Drawing for TIME IS LIFE

USPTO serial 90226522

TIME IS LIFE

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
MARCY, AMY ALFIERI
Law office
TMEG LAW OFFICE 109 - EXAMINING ATTORNEY ASSIGNED

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with TIME IS LIFE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

John Zaccaria

John Zaccaria NOTARO, MICHALOS & ZACCARIA P.C.100 DUTCH HILL ROAD, SUITE 240ORANGEBURG, NY 10962UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
035Promoting collaboration and the exchange of information and resources within the scientific, research, medical, clinical and private communities to achieve advances in the field of cancer treatment; Providing pharmacoeconomic information in the nature of medical and/or research data pertaining to cancer and its treatmentACTIVE—
036Financial sponsorship of clinical and translational trials in the field of cancer treatmentACTIVE—
042Medical and scientific research in the field of molecular profiling and biomarker discovery in cancer patients; medical and scientific research in the field of cancer treatment; providing research information in the nature of medical research data pertaining to cancer and its treatment; conducting translational trials for others in the field of cancer treatment, consisting of a combination of clinical research and scientific research; conducting trials in the field of cancer treatment for others; providing clinical trial information in the nature of medical and scientific research data pertaining to cancer; providing medical research information pertaining to cancer and its treatmentACTIVE—
044Providing medical information featuring profiles of cancer patients' tumours and the associated clinical and molecular data, and medical information pertaining to cancer drugs, biomarkers, biological and tissue samples, and results of clinical studies, via an on-line searchable database; providing tissue biobank services, namely, access to a biobank of human biological and tissue samples; providing medical information concerning quality of life in the fields of the treatment of cancer, the likelihood of success of the treatment of cancer, the physical and psychological impacts of the treatment of cancer on patients and the recovery time from the treatment of cancer; providing medical information in the nature of medical data pertaining to cancer and its treatment; providing psychosocial care information in the nature of medical data pertaining to cancer and its treatment; providing medical information about pharmacovigilance in the nature of medical data pertaining to cancer and its treatment; providing medical information pertaining to cancer and its treatmentACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB2): The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.

DateCodeEventWhat it means
Jul 13, 2024MAB2ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Jul 13, 2024ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Mar 10, 2024GNS2NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED—
Mar 10, 2024GNSIINQUIRY TO SUSPENSION E-MAILED—
Mar 10, 2024CNSISUSPENSION INQUIRY WRITTEN—
Feb 5, 2024RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Jul 15, 2023GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Jul 15, 2023GNSLLETTER OF SUSPENSION E-MAILED—
Jul 15, 2023CNSLSUSPENSION LETTER WRITTEN—
Apr 21, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 21, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 20, 2023ALIEASSIGNED TO LIE—
Apr 12, 2023ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Jan 27, 2023GNS2NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED—
Jan 27, 2023GNSIINQUIRY TO SUSPENSION E-MAILED—
Jan 27, 2023CNSISUSPENSION INQUIRY WRITTEN—
Jul 15, 2022GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Jul 15, 2022GNSLLETTER OF SUSPENSION E-MAILED—
Jul 15, 2022CNSLSUSPENSION LETTER WRITTEN—
Jun 2, 2022TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 2, 2022CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 28, 2022ALIEASSIGNED TO LIE—
May 25, 2022ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Nov 28, 2021GNS2NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED—
Nov 28, 2021GNSIINQUIRY TO SUSPENSION E-MAILED—
Nov 28, 2021CNSISUSPENSION INQUIRY WRITTEN—
Oct 27, 2021RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Apr 19, 2021GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Apr 19, 2021GNSLLETTER OF SUSPENSION E-MAILED—
Apr 19, 2021CNSLSUSPENSION LETTER WRITTEN—
Mar 12, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 11, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 11, 2021TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 25, 2021GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 25, 2021GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 25, 2021CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 24, 2021DOCKASSIGNED TO EXAMINER—
Nov 14, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 3, 2020NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance